Search research articles
Contact Us
Filters
Showing results (91-100 of 102) with videos related to
Page
of 11
Sort By:
The American Journal of Surgical Pathology
|
October 20, 1998
Statistical evaluation of diagnostic and prognostic features of CD30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 cases
B Vergier, M Beylot-Barry, K Pulford, et al.
International Journal of Cancer
|
June 22, 2000
Delays in diagnosis and melanoma prognosis (I): the role of patients
M A Richard, J J Grob, M F Avril, et al.
International Journal of Cancer
|
June 22, 2000
Delays in diagnosis and melanoma prognosis (II): the role of doctors
M A Richard, J J Grob, M F Avril, et al.
Archives of Dermatology
|
March 23, 1999
Melanoma and tumor thickness: challenges of early diagnosis
M A Richard, J J Grob, M F Avril, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 14, 2011
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study
T Jouary, C Leyral, B Dreno, et al.
The British Journal of Dermatology
|
July 8, 2015
Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study Group
C Hurabielle, S Ingen-Housz-Oro, N Ortonne, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 18, 2023
Duration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response: Real-life study
K Khelef, E Maubec, G Jeudy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 2021
Relevance of body mass index as a predictor of systemic therapy outcomes in metastatic melanoma: analysis of the MelBase French cohort data<sup>☆</sup>
Y Di Filippo, S Dalle, L Mortier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 2, 2018
Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort
M Kandel, C Allayous, S Dalle, et al.
Annales De Dermatologie Et De Venereologie
|
September 5, 2025
Impact of the COVID-19 pandemic on melanoma: A retrospective study from the French clinical database of melanoma patients (RIC-Mel)
F Skowron, S Mouret, A Seigneurin, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 102) with videos related to
Sort By:
Page
of 11
The American Journal of Surgical Pathology
|
October 20, 1998
Statistical evaluation of diagnostic and prognostic features of CD30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 cases
B Vergier, M Beylot-Barry, K Pulford, et al.
International Journal of Cancer
|
June 22, 2000
Delays in diagnosis and melanoma prognosis (I): the role of patients
M A Richard, J J Grob, M F Avril, et al.
International Journal of Cancer
|
June 22, 2000
Delays in diagnosis and melanoma prognosis (II): the role of doctors
M A Richard, J J Grob, M F Avril, et al.
Archives of Dermatology
|
March 23, 1999
Melanoma and tumor thickness: challenges of early diagnosis
M A Richard, J J Grob, M F Avril, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 14, 2011
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study
T Jouary, C Leyral, B Dreno, et al.
The British Journal of Dermatology
|
July 8, 2015
Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study Group
C Hurabielle, S Ingen-Housz-Oro, N Ortonne, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 18, 2023
Duration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response: Real-life study
K Khelef, E Maubec, G Jeudy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 2021
Relevance of body mass index as a predictor of systemic therapy outcomes in metastatic melanoma: analysis of the MelBase French cohort data<sup>☆</sup>
Y Di Filippo, S Dalle, L Mortier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 2, 2018
Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort
M Kandel, C Allayous, S Dalle, et al.
Annales De Dermatologie Et De Venereologie
|
September 5, 2025
Impact of the COVID-19 pandemic on melanoma: A retrospective study from the French clinical database of melanoma patients (RIC-Mel)
F Skowron, S Mouret, A Seigneurin, et al.
Page
of 11